Shuvra Ray

817 total citations
33 papers, 456 citations indexed

About

Shuvra Ray is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Shuvra Ray has authored 33 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 18 papers in Genetics and 15 papers in Epidemiology. Recurrent topics in Shuvra Ray's work include Inflammatory Bowel Disease (17 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (6 papers). Shuvra Ray is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (6 papers). Shuvra Ray collaborates with scholars based in United Kingdom, United States and Italy. Shuvra Ray's co-authors include Theresa T. Pizarro, Carlo De Salvo, Jude A. Oben, Junpei Soeda, Angelina Mouralidarane, Jeremy Sanderson, Peter M. Irving, Mark Samaan, Joel Mawdsley and Marco Novelli and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Shuvra Ray

30 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuvra Ray United Kingdom 14 161 154 132 87 74 33 456
Evelina Suraci Italy 13 193 1.2× 134 0.9× 131 1.0× 111 1.3× 41 0.6× 30 493
Liliana Łykowska‐Szuber Poland 16 155 1.0× 206 1.3× 320 2.4× 97 1.1× 47 0.6× 51 663
Sender Jankiel Miszputen Brazil 14 121 0.8× 120 0.8× 197 1.5× 80 0.9× 41 0.6× 48 460
Ulrich Karck Germany 9 66 0.4× 126 0.8× 56 0.4× 167 1.9× 35 0.5× 15 663
Petr Ricanek Norway 12 130 0.8× 220 1.4× 275 2.1× 123 1.4× 27 0.4× 26 578
Luis Carlos Olivar Venezuela 9 134 0.8× 75 0.5× 81 0.6× 45 0.5× 66 0.9× 20 690
Italia Loddo Italy 8 96 0.6× 85 0.6× 203 1.5× 99 1.1× 19 0.3× 11 438
Takuji Fujisawa Japan 13 352 2.2× 115 0.7× 30 0.2× 71 0.8× 58 0.8× 23 559
Carmen Gómez Spain 9 113 0.7× 65 0.4× 66 0.5× 41 0.5× 41 0.6× 14 336
Marie-Anne Maubert France 9 103 0.6× 63 0.4× 77 0.6× 41 0.5× 67 0.9× 17 536

Countries citing papers authored by Shuvra Ray

Since Specialization
Citations

This map shows the geographic impact of Shuvra Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuvra Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuvra Ray more than expected).

Fields of papers citing papers by Shuvra Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuvra Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuvra Ray. The network helps show where Shuvra Ray may publish in the future.

Co-authorship network of co-authors of Shuvra Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Shuvra Ray. A scholar is included among the top collaborators of Shuvra Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuvra Ray. Shuvra Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Dawson, Patrick, Esha Sharma, Robin Dart, et al.. (2022). P19 Risankizumab in crohn’s disease: real world experience from a pre-approval access program. Poster presentations. A45.2–A46. 2 indexed citations
5.
Meade, Susanna, Esha Sharma, Sailish Honap, et al.. (2022). How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?. Frontline Gastroenterology. 14(4). 312–318. 5 indexed citations
6.
Meade, Susanna, Kamal Patel, Raphael P. Luber, et al.. (2022). A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a UK tertiary IBD centre. Alimentary Pharmacology & Therapeutics. 56(4). 646–663. 24 indexed citations
7.
Honap, Sailish, Gareth Parkes, Mark Samaan, et al.. (2021). P103 Ustekinumab: medium-term outcomes from a uk multi-centre real-world cohort. A94.2–A95. 1 indexed citations
8.
Samaan, Mark, Shuvra Ray, Joel Mawdsley, et al.. (2021). P143 Validation of the two-item UC PRO2 against SCCAI, biochemical disease activity and quality of life. A116.2–A117. 1 indexed citations
9.
Salvo, Carlo De, Luca Pastorelli, Christine Petersen, et al.. (2020). Interleukin 33 Triggers Early Eosinophil-Dependent Events Leading to Metaplasia in a Chronic Model of Gastritis-Prone Mice. Gastroenterology. 160(1). 302–316.e7. 49 indexed citations
10.
Honap, Sailish, Esha Sharma, Shuvra Ray, et al.. (2019). PTH-092 Early ‘Real World’ Experience with Tofacitinib for Moderate to Severe Ulcerative Colitis. A78.2–A79. 3 indexed citations
11.
Grassby, Terri, Giuseppina Mandalari, Myriam M.-L. Grundy, et al.. (2017). In vitro and in vivo modeling of lipid bioaccessibility and digestion from almond muffins: The importance of the cell-wall barrier mechanism. Journal of Functional Foods. 37. 263–271. 33 indexed citations
12.
Nguyen, Vi, et al.. (2017). Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre. Canadian Journal of Gastroenterology and Hepatology. 2017. 1–8. 22 indexed citations
13.
Tiraboschi, Juan, Shuvra Ray, Matthew Pace, et al.. (2016). Short Communication: Lack of Effect of Maraviroc Intensification on Blood and Gut Reservoir. AIDS Research and Human Retroviruses. 33(2). 143–146. 6 indexed citations
14.
Mouralidarane, Angelina, Junpei Soeda, Shuvra Ray, et al.. (2014). Non-Alcoholic Fatty Pancreas Disease Pathogenesis: A Role for Developmental Programming and Altered Circadian Rhythms. PLoS ONE. 9(3). e89505–e89505. 38 indexed citations
15.
Salvo, Carlo De, Shuvra Ray, & Theresa T. Pizarro. (2014). Mechanisms and Models for Intestinal Fibrosis in IBD. Digestive Diseases. 32(Suppl. 1). 26–34. 12 indexed citations
16.
Goel, Rishi, Mark G. Ward, Kamal Patel, et al.. (2014). Su1101 Indeterminate and Inconclusive Results Are Common When Using Interferon Gamma Release Assay As Screening for TB in Patients With IBD. Gastroenterology. 146(5). S–374. 1 indexed citations
17.
Ray, Shuvra, Carlo De Salvo, & Theresa T. Pizarro. (2014). Central role of IL-17/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis. Current Opinion in Gastroenterology. 30(6). 531–538. 44 indexed citations
18.
Patel, Kamal, Joanne L. Ooi, Shuvra Ray, Nyree Griffin, & Jude A. Oben. (2013). Abdominal pain following obesity treatment. Gut. 63(2). 364–365. 2 indexed citations
19.
Patel, Pritash, Jonathan Brostoff, Helen Campbell, et al.. (2013). Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease. Clinical and Translational Allergy. 3(1). 26–26. 26 indexed citations
20.
Mouralidarane, Angelina, et al.. (2012). Recent advancements in drug treatment of obesity. Clinical Medicine. 12(5). 456–460. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evelina Suraci Breakdown of academic impact, for papers by Liliana Łykowska‐Szuber Breakdown of academic impact, for papers by Sender Jankiel Miszputen Breakdown of academic impact, for papers by Ulrich Karck Breakdown of academic impact, for papers by Petr Ricanek Breakdown of academic impact, for papers by Luis Carlos Olivar Breakdown of academic impact, for papers by Italia Loddo Breakdown of academic impact, for papers by Takuji Fujisawa Breakdown of academic impact, for papers by Carmen Gómez Breakdown of academic impact, for papers by Marie-Anne Maubert
Rankless by CCL
2026